Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

New Florida Law Will Impose A Third-Party Administrator Licensing Requirement for Pharmacy Benefit Managers

By Bruce D. Platt & Thomas A. Range on May 4, 2023
Email this postTweet this postLike this postShare this post on LinkedIn

On May 3, 2023, the Florida governor signed a comprehensive law (SB 1550) regarding pharmacy benefit managers (PBMs). This new law imposes significant new requirements on PBMs. This article discusses only one of these new requirements: a PBM must obtain a license, called a certificate of authority, to act as an insurance administrator, which is commonly referred to as a third-party administrator, or TPA.

Before enactment of this new law, a Florida PBM was only required to register with the Office of Insurance Regulation (OIR). As provided in section 624.490, Florida Statutes, the registration process is straightforward and only requires minimal information (PBM’s name, address, and a list of its officers and directors).

Effect of new law on licensing

Under the new law, a PBM will be required to obtain a TPA license from the OIR. In contrast to the current PBM registration process, the TPA licensure process is much more extensive and involves the submission of comprehensive information that will allow the OIR to evaluate a PBM’s finances and assess the background and suitability of the PBM’s officers, directors, and owners. Although some provisions of the new law may require further regulatory interpretation, we believe the following list highlights the main requirements a PBM will likely need to meet to obtain its Florida TPA license:

  • Submission of biographical affidavits for officers, directors, and individuals who own 10 percent or more of the TPA (direct or indirect ownership)
  • Completion of background investigative reports for officers, directors, and individuals who own 10 percent or more of the TPA
  • Fingerprints for officers, directors, and individuals who own 10 percent or more of the TPA
  • The PBM’s plan of operations
  • A fidelity bond
  • Organizational chart showing the PBM’s relationship to all companies in its holding company system (identifying all companies from the PBM’s immediate parent to the ultimate owner, including all officers, directors, and owners of these companies)
  • Submission of the PBM’s annual financial statements
  • Copies of the PBM’s contract templates with pharmacies
  • Copies of all subcontracts in support of the PBM’s operations

Practical considerations

The OIR’s review of license applications, including TPA applications, is very detailed and thorough. When preparing a TPA application, the applicant needs to ensure that it carefully scrutinizes each section and completely provides the information or material required. For example, when completing the biographical affidavits, each blank on the affidavit must be addressed. If a particular request is not applicable, state “N/A” in the affidavit, even if the answer seems obvious from the context. Completely addressing each application requirement will reduce the OIR’s requests for additional information and expedite the application’s processing.

Importantly, there could be serious concerns with the timing and processing of applications for PBMs to become licensed as TPAs. If a PBM is currently registered with the OIR, it has until January 1, 2024, to obtain its license. The TPA licensure application can take up to three months to complete, and the biographical affidavits and background reports alone can take up to a month or longer to complete and process. Because the OIR frequently asks applicants for additional or clarifying information during the application process, it can take even longer. There are currently 74 registered PBMs in Florida. Assuming all these PBMs submit TPA license applications at approximately the same time, there could be a significant delay in processing applications.

If a new PBM wants to start operations, or if an existing PBM wishes to continue operating as a PBM after January 1, 2024, we strongly encourage the submission of a TPA license application at the earliest possible time. Specifically, the new law takes effect July 1, 2023, so it would be advisable to submit the license application on or near that date. From informal discussions with the OIR, we understand that the OIR is considering revising the TPA application form to include the new requirements for PBM licensing.

Akerman has significant experience with TPA licensing and the OIR’s licensing process and is available to assist with the preparation and submission of license applications.

Photo of Bruce D. Platt Bruce D. Platt

Bruce Platt serves as managing partner of Akerman’s Tallahassee office. With a background in healthcare and medical technology, he helps insurers, providers, and related companies navigate federal and state regulations and administrative law. Clients rely on Bruce for guidance on complex regulations, such…

Bruce Platt serves as managing partner of Akerman’s Tallahassee office. With a background in healthcare and medical technology, he helps insurers, providers, and related companies navigate federal and state regulations and administrative law. Clients rely on Bruce for guidance on complex regulations, such as the Florida Insurance Code, HIPAA, and the Affordable Care Act. His clients include Aetna, AvMed, Florida Blue, Health First, and UnitedHealthcare, among others.

Read more about Bruce D. PlattEmail
Show more Show less
Photo of Thomas A. Range Thomas A. Range

Having spent nearly a decade working for a national biopharmaceutical company, including five years in management, Tom Range possesses invaluable experience in the biotechnology sector, which allows him to better serve his broad client base.  Because he has worked in facilities regulated by…

Having spent nearly a decade working for a national biopharmaceutical company, including five years in management, Tom Range possesses invaluable experience in the biotechnology sector, which allows him to better serve his broad client base.  Because he has worked in facilities regulated by the FDA, the State of Florida, and foreign authorities, Tom understands the challenges facing companies whose success depends on their ability to navigate often-murky regulatory waters.

Read more about Thomas A. RangeEmail
Show more Show less
  • Posted in:
    Insurance
  • Blog:
    Health Law Rx
  • Organization:
    Akerman LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo